Shiv Uniform Center

Manufacturer	MYLAN
Brand	abevmy
Packaging	Injection
Dosage Form	400 mg/16 ml & 100 mg/ 4ml
Warning and Precaution	Not to be taken by Pregnant Women
Storage	2 - 8 c
Country of Origin	Made in India

Abevmy Bevacizumab 400 Mg Injection, Brand: Mylan, Treatment: cancer  and Covid

Dose/Strength

500MG

CYRAMZA® is a human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist indicated:
• as a single agent or in combination with paclitaxel, for treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. (1.1)

Brand	lily
Packaging Type	vial

ALIMTA in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. ... The recommended dose of ALIMTA is 500 mg/m² of body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle.

Brand	mylan
Product Type	Finished Product
Certification	FDA

Hertraz is indicated for the treatment of HER2-positive metastatic breast cancer and is available in two strengths, 440 mg and 150 mg. Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India.